Form 8-K HALLIBURTON CO For: Apr 23
http://archive.fast-edgar.com/20240423/ACL2M222Z22282N2222M22Z2LOARN9222262
Filed on: April 23, 2024
Form D VIVIFI MEDICAL SPV 2023
http://archive.fast-edgar.com/20240423/A9V2322MG222F222222322Z22D9JH2222262
Filed on: April 23, 2024
Form 6-K ONECONNECT FINANCIAL For: Apr 23
http://archive.fast-edgar.com/20240423/AGB4W22C8Z22V2Z222JD2WZZ35WOZ2R23262
Filed on: April 23, 2024
Form 8-K SHERWIN WILLIAMS CO For: Apr 23
0000089800false00000898002024-04-232024-04-23UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): April 23, 2024THE SHERWIN-WILLIAMS COMPANY (Exact Name of Registrant as Specified in Charter)Ohio1-0485134-0526850(State or other jurisdiction of incorporation)(Commission file number)(I.R.S. Employer Identification... (continue reading...)
Form 6-K ProQR Therapeutics N.V. For: Apr 23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of April 2024
Commission File Number: 001-36622
PROQR THERAPEUTICS N.V.
Zernikedreef 9
2333 CK Leiden
The Netherlands
Tel: +31 88 166 7000
(Address, Including Zip Code, and Telephone Number,
Including Area Code, of... (continue reading...)
More SEC Filings
View Older Stories-
Form DEFA14A Syros Pharmaceuticals,
-
Form DEFA14A Cabaletta Bio, Inc.
-
Form 8-K KIMBERLY CLARK CORP For: Apr 23
-
Form 8-K Philip Morris Internatio For: Apr 23
-
Form 6-K Mobilicom Ltd For: Apr 23
-
Form DEF 14A Syros Pharmaceuticals, For: Jun 05
-
Form DSTRBRPT International Finance
-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form DSTRBRPT International Finance
-
Form DEF 14A Cabaletta Bio, Inc. For: Jun 03
-
Form DSTRBRPT International Finance
-
Form 8-K Seres Therapeutics, Inc. For: Apr 19
-
Form 10-Q MANHATTAN BRIDGE CAPITAL For: Mar 31
-
Form 8-K ClearSign Technologies For: Apr 22
-
Form 8-K Theriva Biologics, Inc. For: Apr 23
-
Form 10-Q MBC FUNDING II CORP. For: Mar 31
-
Form 6-K Tiziana Life Sciences For: Apr 23
-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form 8-K Option Care Health, Inc. For: Apr 23
-
Form 8-K RTX Corp For: Apr 23
-
Form 10-Q BANK OF HAWAII CORP For: Mar 31
-
Form 8-K PENTAIR plc For: Apr 23
-
Form 8-K RYDER SYSTEM INC For: Apr 23
-
Form 8-K MSCI Inc. For: Apr 23
-
Form 1-K Red Oak Capital Fund For: Dec 31
-
Form 8-K QUEST DIAGNOSTICS INC For: Apr 23
-
Form D Emma Grace Healing Hospi
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 8-K XEROX CORP For: Apr 23 Filed by: Xerox Holdings Corp
-
Form ARS UNIVERSAL HEALTH REALTY For: Dec 31
-
Form 8-K CARDINAL HEALTH INC For: Apr 23
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form DEFA14A UNIVERSAL HEALTH REALTY
-
Form 8-K Aquaron Acquisition Corp For: Apr 19
-
Form 20-F ONECONNECT FINANCIAL For: Dec 31
-
Form D Palumni-SM-0404 Fund I,
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 6-K Ermenegildo Zegna N.V. For: Apr 23
-
Form 10-Q HERC HOLDINGS INC For: Mar 31
-
Form 1-K Future Cardia, Inc. For: Dec 31
-
Form 8-K HERC HOLDINGS INC For: Apr 23
-
Form DEF 14A UNIVERSAL HEALTH REALTY For: Jun 05
-
Form 8-K JETBLUE AIRWAYS CORP For: Apr 23
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 6-K Baozun Inc. For: Apr 23
-
Form D MU-0311 Fund II, a serie
-
Form 8-K Flutter Entertainment For: Apr 23
-
Form 20-F Yalla Group Ltd For: Dec 31
-
Form 10-Q GENERAL ELECTRIC CO For: Mar 31
-
Form SC TO-I/A CONX Corp. Filed by: CONX Corp.